ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PYC Physiomics Plc

1.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.50 1.40 1.60 1.50 1.50 1.50 195,426 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.29 2.03M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.50p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £2.03 million. Physiomics has a price to earnings ratio (PE ratio) of -4.29.

Physiomics Share Discussion Threads

Showing 21826 to 21847 of 30125 messages
Chat Pages: Latest  881  880  879  878  877  876  875  874  873  872  871  870  Older
DateSubjectAuthorDiscuss
19/6/2018
17:40
Interesting to see Glaxo and Astra Zeneca teaming up with Government on this initiative

A new centre to help companies develop processes and technologies for manufacturing medicines could benefit future generations by helping new medicines reach patients safely and quickly.

By supporting both start-ups and multinational pharmaceutical companies it’s hoped that the speed in which new medicines reach the market will increase significantly.

It is one of the biggest health challenges facing society and aligns with the leading-edge healthcare challenge – part of the government’s modern Industrial Strategy. The project will receive £13 million from the Industrial Strategy Challenge Fund. This funding is provided by UK Research and Innovation, through Innovate UK.

The rest of the funding for the £56 million centre will be provided by Scottish Enterprise, alongside private industry support from AstraZeneca and GSK.

the stigologist
19/6/2018
17:38
Wall Of Money



Competition information
the competition is open, and the deadline for applications is at midday on 1 August 2018
a UK-based business, NHS organisation or trust, hospital, research organisation, charity or Academic Health Science Network can lead a project, working in collaboration with others
at least 2 organisations must apply per grant award
total project costs should be between £14 million and £20 million
businesses could attract up to 70% of their eligible costs
applications that meet the quality threshold will be invited to interview in September 2018
a briefing event will be held on 15 June 2018

the stigologist
19/6/2018
13:54
Have been out of this for months but always followed. Back in today and Imo is an excellent buy at this price. Gla
jungmana
19/6/2018
11:49
PWhite, it's no different to that other scam PCGE.A complete fiasco that is.Stigologist is now such a bad smell around these pump and dump scam stocks, he really needs to use one of his other avatars, or give it up altogether.
festario
19/6/2018
11:48
Your opinion is meaningless.

There are pro investors who've met Dr Jim Millen and done their DD who reckon this is worth 100p+

The ex-founder reckons this will be worth 100p+

Dr Jim Millen only becomes a millionaire off his options if the price is 100p+

Merck, Glaxo et al don't sign up with a enabling tech company like this unless it has something unique they can't do/get in-house

the stigologist
19/6/2018
10:07
News very overdue now.
I expect Dr Millen is hostage to Theresa May NHS Brexit Dividend ramping schedule

the stigologist
19/6/2018
07:21
Another contract win coming this week
tmmalik
18/6/2018
11:14
If PYC get a 250-500k Govt grant they'll have an unprecedented c£1m of firepower to attack potential billion pound plus global markets it could moonshoot to over 100p as it has in the past
the stigologist
18/6/2018
11:12
A stock that can do 1p to 32p in 48 hours has no limits
the stigologist
18/6/2018
11:10
Probably around 4.75-5p this may hit a brick wall. Would be nice to see a rumour take some wind to cheat this over 5p. I'll take it which way it comes!!
margic
18/6/2018
11:03
We are overdue now to hear about PYC grant awards from multiple Government funds
the stigologist
18/6/2018
11:03
Nobody really understands this Company on AIM. PIs Brokers Analysts Instis all clueless.

It is understood by Government Big Pharma and likes of Certara Simulations Plus GRAIL Deepmind etc so if market continues to ignore it it'll get bought out

Why Jim was talking about being on the beach. Multi millionaire retirement beckons

the stigologist
18/6/2018
10:59
The Government talking of spending billions on NHS

Physiomics could grab a chunk of that and be totally mega transformed

Could massively improve efficiency of ALL cancer drug regimes by working out correct dosing and appropriate regimens

This will be a £1bn+ company one day I reckon

the stigologist
18/6/2018
10:54
Major contract news this week.
IMHO.

fqr714bhp
18/6/2018
10:52
If anyone could plot those lines and lost a chart much appreciated.Cut the 32p spike, down trend line, down to today's price.Horizontal line, under bars from 4p lows, Horizonal line from previous support gapped through, Horizontal line from highest highs, Macd 200 and 50 emaVolumeIf possible upper trend line using 32p spike.Please and thanks in advance. I don't have the tools for this. Not on stocks!
margic
18/6/2018
10:45
Just couldn't be any more squeezed this little sp, with volume this will move hard which ever the next direction it choose. The jury is kinda out but I'll let everyone else debate that. Technically, ouff, there's little space left really to faff around. It's ''one way or another'' very soon. At least there should be some action again at the table. Still trying to learn on the ways these are controlled different to more liquid products, such as usd/jpy as an example, silver, gold etc...Make a trend line, throw a few horizontals in from 4p+ one under 4p+ and you can gauge where this is at. What we do know with aim is news can force the hand and often complements nicely with the techs. So next news should be key. Unless there's a decent sideways piece to follow. Timing will be key and wording even more important. A soft contract now won't be of any help other than to perhaps consolidate this so here and maybe slightly lower creating a physiologic support above say 3p, then any poor placings can take the share price all the way down to that line under 4p I just said to plot. Any great contract win/grant/investment/power patent/mou/Partnership/J.V... etc should blow this out the Park. With markets starting to look weak as they dance high, 2020 looks a realistic target for the realisation to kick in, you'd bet if aim stocks are to have a last hooray, which every other time they have, Sep-Nov 2017 blast will he reappeared between June-sept and maybe on as far as march 2019 before it all starts hitting the fan. Could be a great time to have money in aim stocks as another subject, that can't help but link. Or it could be damp squids for all. Let's hope trends are our friends. You see the plan guys, invest what you can lose or you're willing to lose, play the game and the whole market, believe, have hope, be wise, have knowledge. If your not in it you can't win it, if you win it someone will be there to hope you next bin it. Aim for 2019 and have fun till then, if the uk investor is going to have its time it should be starting around now. Bonanza time. Great time to market and brand 'aim/Alternative' against cryptos and bring in a new wave of investors when the banks start to cry 'timber' in 2020+ (a bit). 'I've taken out a credit card in granny's name to buy some stocks. I don't need my job anymore everyone is quitting theirs' (the 2021 guy) or 'yeah all sweet mate, few of my mates are struggling at the moment but they should be ok, I help them where I can, otherwise not really investing on the 'aim' stocks anymore, I just well take things as they come' (today's investor, hopefully!) !!!!!Which do you wanna be I ask myself, can PYC produce the best return to make the second more likely? Well if they can produce a cracker from somewhere, 30p+ might be seen as selling short all too soon. It won't be like old, you'll always be able to recover 50% of what you hold now if you have to sell at a bad time for your pocket (again, this is why you should invest what you can live without) and 90% of what you hold now if you can always afford to wait say 3-4 weeks before you have to sell (again, the comfort of investing what you can afford to live without) this is also good for you investment strategy as you must always have an entry and exit plan. Exit plan can always change however only with logic. Money to be lost here for sure only a fool would doubt it but that's relevant to any stock. In PYC's case, at any given moment, 1 good deal is a game changer for all involved. To me, this is a great outside bet. But then again, I'm well comfortable with my position here.Gl all no apologise for my typos!
margic
18/6/2018
10:11
Big buys started this morningSee if it go back to 6p this week
tmmalik
17/6/2018
14:16
Just wait for my reaction if this ever gets to 9p and I break even
spacedust
17/6/2018
13:01
With Dr Orrell giving one of the keynote speeches at ISF conferences today on forecasting across a spectrum of social and scientific disciplines.

He doesn't seem to be much help at forecasting the companies future forward, as he's been a team member several years.
Dr David Orrell, Principal Consultant, Modelling & Simulation and Scientific Advisory Board member.

myamay16
17/6/2018
12:53
Spacedust, would have loved to see what your comments would have been if he had won the following Small Cap 2018 Awards.

Executive Director of the Year
Zillah Byng-Thorne (CEO) and Penny Ladkin-Brand (CFO) – Future plc
Dr. Stuart Green, CEO – Zoo Digital Group PLC
Chris Gurry, Group Managing Director – CML MicroSystems PLC
Tom Ilube, CEO – Crossword Cybersecurity PLC
Dr Markku Jalkanen, CEO – Faron Pharmaceuticals
Bobby Kalar, CEO – Yu Group PLC
Dr. James Millen, CEO – Physiomics PLC
Ian Simm, CEO – Impax Asset Management Group PLC
Frazer Thompson, CEO – Chapel Down Group PLC
Andrew Wass, CEO – Gear4Music Holdings PLC

No need to worry, the winner was:-

Executive Director of the Year

Bobby Kalar, CEO – Yu Group PLC

hxxp://www.smallcapnetwork.co.uk/awards-2018/

myamay16
15/6/2018
22:48
flesh

They can issue another 15 million more shares before the next AGM.

How many they issue if any all depends on how much more money mug punters are prepared to invest in this stock. PYC don't need anymore money for what they are doing, basically laboratory research for Oxford University.

However if enough clowns think the shares are cheap or they are investing in the next Astra Zeneca then new shares will be drip fed on a pro rata basis.

pwhite73
15/6/2018
18:53
Loads of.millions in my guess. 400k buys don't nudge the pr8ce up.will be below 4p anytime now.

Where are the contracts
Where is the grant
Jim cunningham

spacedust
Chat Pages: Latest  881  880  879  878  877  876  875  874  873  872  871  870  Older

Your Recent History

Delayed Upgrade Clock